Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.

  • Palma, Francesco
  • Affinito, Alessandra
  • Nuzzo, Silvia
  • Roscigno, Giuseppina
  • Scognamiglio, Iolanda
  • Ingenito, Francesco
  • Martinez Garcia, Maria Dolores
  • Franzese, Monica
  • Zanfardino, Mario
  • Soricelli, Andrea
  • Fiorelli, Alfonso
  • Condorelli, Gerolama
  • Quintavalle, Cristina
Lung cancer is still the leading cause of death by cancer worldwide despite advances both in its detection and therapy. Multiple oncogenic driver alterations have been discovered, opening the prospective for new potential therapeutic targets. Among them, KRAS mutations represent the most frequent oncogene aberrations in non-small cell lung cancer (NSCLC) patients with a negative prognostic impact, but effective therapies targeting KRAS are not well characterized yet. Here, we demonstrate that the microRNA miR-34c-3p is a positive prognostic factor in KRAS-mutated NSCLC patients. Firstly, looking at the TGCA dataset, we found that high miR-34c-3p expression correlated with longer survival of KRAS-mutated NSCLC patients. In vitro assays on immortalized and patient-derived primary NSCLC cells revealed that miR-34c-3p overexpression increased apoptosis and lowered proliferation rate in KRASmut cells. Computational analysis and in vitro assays identified CDK1, one of the most promising lethal targets for KRAS-mutant cancer, as a target of miR-34c-3p. Moreover, the combination of CDK1 inhibition (mediated by RO3306) and miR-34c-3p overexpression resulted in an additive effect on the viability of KRASmut-expressing cells. Altogether, our findings demonstrate that miR-34c-3p is a novel biomarker that may allow tailored treatment for KRAS-mutated NSCLC patients.
UVaDOC. Repositorio Documental de la Universidad de Valladolid
Publicación Artículo científico (JournalArticle)

The Incorporation of etanercept into a porous tri-layer scaffold for restoring and repairing cartilage tissue

  • Campos, Yaima
  • Fuentes, Gastón
  • Almirall, Amisel
  • Que, Ivo
  • Schomann, Timo
  • Chung, Chih Kit
  • Jorquera Cordero, Carla
  • Quintanilla Sierra, Luis
  • Rodríguez Cabello, José Carlos
  • Chan, Alan
  • Cruz, Luis
Producción Científica, Cartilage diseases currently affect a high percentage of the world’s population. Almost all of these diseases, such as osteoarthritis (OA), cause inflammation of this soft tissue. However, this could be controlled with biomaterials that act as an anti-inflammatory delivery system, capable of dosing these drugs over time in a specific area. The objective of this study was to incorporate etanercept (ETA) into porous three-layer scaffolds to decrease the inflammatory process in this soft tissue. ETA is a blocker of pro-inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). For this reason, the scaffold was built based on natural polymers, including chitosan and type I collagen. The scaffold was grafted next to subchondral bone using hydroxyapatite as filler. One of the biomaterials obtained was also crosslinked to compare its mechanical properties with the non-treated one. Both samples’ physicochemical properties were studied with SEM, microCT and photoacoustic imaging, and their rheological properties were also compared. The cell viability and proliferation of the human chondrocyte C28/I2 cell line were studied in vitro. An in vitro and in vivo controlled release study was evaluated in both specimens. The ETA anti-inflammatory effect was also studied by in vitro TNF-α and IL-6 production. The crosslinked and non-treated scaffolds had rheological properties suitable for this application. They were non-cytotoxic and favoured the in vitro growth of chondrocytes. The in vitro and in vivo ETA release showed desirable results for a drug delivery system. The TNF-α and IL-6 production assay showed that this drug was effective as an anti-inflammatory agent. In an in vivo OA mice model, safranin-O and fast green staining was carried out. The OA cartilage tissue improved when the scaffold with ETA was grafted in the damaged area. These results demonstrate that this type of biomaterial has high potential for clinical applications in tissue engineering and as a controlled drug delivery system in OA articular cartilage., European Union through the Erasmus PLUS doctoral fellowship (project 2015-1-NL01-KA 107-008639), VIDI personal grant (project 723.012.110)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tea Bags for Fmoc Solid-Phase Peptide Synthesis: An Example of Circular Economy

  • Guzmán, Fanny
  • Gauna, Adriana
  • Roman, Tanya
  • Luna, Omar
  • Álvarez, Claudio
  • Pareja-Barrueto, Claudia
  • Mercado, Luis
  • Albericio, Fernando
  • Cárdenas, Constanza
Peptide synthesis is an area with a wide field of application, from biomedicine to nanotechnology, that offers the option of simultaneously synthesizing a large number of sequences for the purpose of preliminary screening, which is a powerful tool. Nevertheless, standard protocols generate large volumes of solvent waste. Here, we present a protocol for the multiple Fmoc solid-phase peptide synthesis in tea bags, where reagent recycling steps are included. Fifty-two peptides with wide amino acid composition and seven to twenty amino acid residues in length were synthesized in less than three weeks. A clustering analysis was performed, grouping the peptides by physicochemical features. Although a relationship between the overall yield and the physicochemical features of the sequences was not established, the process showed good performance despite sequence diversity. The recycling system allowed to reduce N, N-dimethylformamide usage by 25–30% and reduce the deprotection reagent usage by 50%. This protocol has been optimized for the simultaneous synthesis of a large number of peptide sequences. Additionally, a reagent recycling system was included in the procedure, which turns the process into a framework of circular economy, without affecting the quality of the products obtained., This research was funded by grants to F.G. (REDES 180203 and Fondecyt 1210056) from the National Agency for Research and Development (ANID), Chile. This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska Curie grant agreement No. 861190 (PAVE). The work of Omar Luna in Spain is funded by PAVE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Amide Formation: Choosing the Safer Carbodiimide in Combination with OxymaPure to Avoid HCN Release

  • Manne, Srinivasa Rao
  • Luna, Omar
  • Acosta, Gerardo A.
  • Royo, Miriam
  • El-Faham, Ayman
  • Orosz, Gyorgy
  • de la Torre, Beatriz G.
  • Albericio, Fernando
It has been reported that DIC can react with OxymaPure to render an oxadiazole compound with the concomitant formation of HCN. Here we demonstrate that this reaction is not a feature of all carbodiimides but rather depends on the alkyl structure that flanks the two N atoms of the carbodiimide. Furthermore, we have identified two carbodiimides, TBEC and EDC·HCl, whose reaction with OxymaPure is exempt from HCN formation., We thank Yoav Luxembourg (Luxembourg Bio Technologies) for encouraging this work. This project received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Marie Skłodowska-Curie Grant Agreement 861190 (PAVE). O.L.’s work was funded by PAVE. The authors acknowledge an American Chemical Society (ACS) Green Chemistry Institute (GCI) Pharmaceutical Roundtable Ignition Grant awarded to S.R.M. The work carried out in South Africa was partially funded by the National Research Foundation (NRF) (Blue Sky’s Research Programme 120386). Peptide preparation was performed at the NANBIOSIS–CIBER BBN Peptide Synthesis Unit (U3)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC)

  • Luna, Omar F.
  • Perez, Yomkippur V.
  • Ferrari, Daniele P.
  • Sayedipour, Sana S.
  • Royo, Miriam
  • Acosta, Gerardo A.
  • Cruz, Luis J.
  • Alves, Frauke
  • Agner, Erik
  • Sydnes, Magne O.
  • Albericio, Fernando
Peptide-based cancer vaccines have shown promising results in preclinical trials focusing on tumor immunotherapy. However, the presence of hydrophobic amino acid segments within these peptide sequences poses challenges in their synthesis, purification, and solubility, thereby hindering their potential use as cancer vaccines. In this study, we successfully synthesized peptide sequences derived from mesothelin (MSLN), a tumor-associated antigen overexpressed in pancreatic ductal adenocarcinoma (PDAC) by conjugating them with monodisperse polyethylene glycol (PEG). By PEGylating mesothelin epitopes of varying lengths (ranging from 9 to 38 amino acids) and hydrophobicity (60-90%), we achieved an effective method to improve the peptide yield and facilitate the processes of synthesis and purification. PEGylation significantly enhanced the solubility, facilitating the single-step purification of lengthy hydrophobic peptides. Most importantly, PEGylation did not compromise cell viability and had little to no effect on the immunogenicity of the peptides. In contrast, the addition of a palmitoyl group to increase immunogenicity led to reduced yield and solubility. Overall, PEGylation proves to be an effective technique for enhancing the solubility and broadening the range of utility of diverse long hydrophobic peptides., The project received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie PAVE-ITN project (grant agreement no. 861190)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

[Dataset] Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC)

  • Luna, Omar F.
  • Perez, Yomkippur V.
  • Ferrari, Daniele P.
  • Sayedipour, Sana S.
  • Royo, Miriam
  • Acosta, Gerardo A.
  • Cruz, Luis J.
  • Alves, Frauke
  • Agner, Erik
  • Sydnes, Magne O.
  • Albericio, Fernando
Peptide-based cancer vaccines have shown promising results in preclinical trials focusing on tumor immunotherapy. However, the presence of hydrophobic amino acid segments within these peptide sequences poses challenges in their synthesis, purification, and solubility, thereby hindering their potential use as cancer vaccines. In this study, we successfully synthesized peptide sequences derived from mesothelin (MSLN), a tumor-associated antigen overexpressed in pancreatic ductal adenocarcinoma (PDAC) by conjugating them with monodisperse polyethylene glycol (PEG). By PEGylating mesothelin epitopes of varying lengths (ranging from 9 to 38 amino acids) and hydrophobicity (60-90%), we achieved an effective method to improve the peptide yield and facilitate the processes of synthesis and purification. PEGylation significantly enhanced the solubility, facilitating the single-step purification of lengthy hydrophobic peptides. Most importantly, PEGylation did not compromise cell viability and had little to no effect on the immunogenicity of the peptides. In contrast, the addition of a palmitoyl group to increase immunogenicity led to reduced yield and solubility. Overall, PEGylation proves to be an effective technique for enhancing the solubility and broadening the range of utility of diverse long hydrophobic peptides., The project received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie PAVE-ITN project (grant agreement no. 861190)., Peer reviewed